List of Excipients in Drugs From Gilead Sciences

✉ Email this page to a colleague

Excipients in drugs from Gilead Sciences

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Gilead Sciences	TRODELVY	sacituzumab govitecan	55135-132	2-(N-MORPHOLINO)ETHANESULFONIC ACID
Gilead Sciences	TRODELVY	sacituzumab govitecan	55135-132	POLYSORBATE 80
Gilead Sciences	TRODELVY	sacituzumab govitecan	55135-132	TREHALOSE
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	CELLULOSE, MICROCRYSTALLINE	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	COPOVIDONE K25-31	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	CROSCARMELLOSE SODIUM	2027-12-22
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.